EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
European Lead Factory
Head of European Screening Centre
Ton Rijnders is the Head of Screening at the European Lead Factory He holds a PhD in molecular biology and has an extensive experience with drug discovery in pharma with increasing managerial and scientific responsibilities Since November Ton is the General Director of Oncode Institute and has been involved since the very beginning in European Lead Factory via the partner Lygature
Articles
Current Research on Plant miRNA and Its Application in Disease Prevention
Natural compounds are becoming more popular as reliable sources of disease prevention due to their lower toxicity ease of availability and minor complications in therapeutic interventions Let food be thy medicine and medicine be thy food Hippocrates said nearly years ago implying that both food consumption and disease occurrence influence an individuals health Aman and Masood Bioactive compounds...
Research Insights
Targeting Blood-brain-barrier Transcytosis – Perspectives For Drug Delivery
Abstract Efficient transcytosis across the bloodbrainbarrier BBB is an important strategy for accessing drug targets within the central nervous system CNS Despite extensive research the number of studies reporting successful delivery of macromolecules or macromolecular complexes to the CNS has remained very low In order to expand current research it is
Case Studies
Impact Of Substitution Among Generic Drugs On Persistence And Adherence:a Retrospective Claims Data Case Study
Abstract Once the period of exclusivity on a reference medicine expires it is possible to apply for marketing of a generic version of that medicine By definition a generic product is considered interchangeable with the innovator brand product when it demonstrates the same qualitative and quantitative composition in active substances the same pharmaceutical form and bi...
Techno Trends
Novel Patho-Seq Assay Discovered for the Detection of Bacteria
Pathogenomix Inc discovered novel PathoSeq assay PathoSeq uses Next Generation Sequencing for the rapid identifaction of bacteria presented in human sample through dangerous and lifethreatening infections PathoSeq detects hundreds of clinically relevant bacteria collected from wide
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
When Orphan Drugs Make All the Difference
Sue Lee has worked for World Courier for 25 years. During this time she has experienced a variety of customer service and operational functions, including the setting up of numerous, multi-national, clinical sites for the transportation of biological samples. She orchestrated the shipping of thousands of shipments with very specific temperature requirements to a host of challenging locations, and each presenting their own obstacles and dilemmas.
Syringe-like Bacterial Nanomachine Emerges as Potential Therapeutics Delivery Device
I am Chanchal Kumawat. I started my journey in science as Ph.D. student at Regional Centre for Biotechnology and continued as postdoctoral fellow at Max Perutz labs, Austria. I enjoyed making scientific discoveries in the laboratory and now, enjoy communicating it as a science writer.
Is Convex Dose Dependence A Side Effect That Multiple Drug Treatment Causes?
Y-h. Taguchi obtained Dr. Sci. of Physics from Tokyo Institute of Technology. He has published papers in major journals, including Scientific Reports and PLoS ONE,a monograph from Springer International and is serving as academic editors in journals including PLoS ONE, BMC Medical Genomics and Frontiers in Genetics:RNA.
TurkiTurki received a PhD in computer science from the New Jersey Institute of Technology. He has published papers in journals, including Expert Systems with Applications, Knowledge-Based Systems, and PLoS ONE. Dr. Turki is an editorial board member of Computers in Biology and Medicine and Sustainable Computing: Informatics and Systems.
Viksit Bharat@ 2047 envisioned the Indian Pharma Industry
Professor Md. Faiyazuddin, a distinguished academician with extensive experience working across the government, public and private sectors, sought to leverage his sixteen-year background in pharmacy education, product development, research consultation, and social pharmacy outreach activities in academia and industry. He is a Senior Professor and former Dean, R&D, Al-Karim University, who is lecturing on health and drug delivery research and holds visiting positions at prestigious universities in India and abroad. He has successfully completed research grants from various R&D agencies, such as SERB-DST and foreign agencies (DSR-UoH, DST, UiTM, Malaysia, Sick’s Children Hospital, Canada) worth Rs. 1.12 Million INR. With more than 120 research, conference, and review manuscripts, dozens of books and chapters, 15 accolades and awards, and various IPR have contributed greatly to the pharm fraternity of India. In addition to his daily job, Dr. Faiyazuddin has a keen interest in connecting researchers worldwide for practicing safe drugs under the flagship of the International Pharmaceutical Forum (a community of more than 250 pharma stalwarts across the globe).
Yogesh Subhash Chaudhari, a passionate educator at Dr L H Hiranandani College of Pharmacy, has contributed significantly to this field through research and review of papers in prestigious journals. His insights on AI for Pharmacist Newsletters on Linkedin are as follows.
The Role of Bioinformatics in Accelerating Translational Research
Vasundhara Dauneria is a biotechnology professional with over six years of experience spanning genomics, next-generation sequencing, and bioinformatics. She has worked across wet-lab and computational research environments, with hands-on expertise in NGS workflows, assay development, and multi-omics data analysis. Her work focuses on applying data-driven approaches to support translational research and precision medicine initiatives.
press releasesRead more...
Gaelic and Athlone Labs Launch Dual Source Strategy at CPHI Milan
Following a horizontal acquisition in December the companies are realising marked synergies under an ambitious integration program that has successfully aligned manufacturing processes
Roche announces grand opening of its Innovation Center Boston to drive advancements in Cardiovascular, Renal and Metabolic diseases
Roche SIX RO ROP OTCQX RHHBY announced today the grand opening of the Roche Genentech Innovation Center Boston expanding Roche and Genentechs US research presence in one
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
Ultragenyx Pharmaceutical Inc NASDAQ RARE today announced that the US Food and Drug Administration FDA granted standard full approval of FAYUVI rebisufligene etisparvovechopf
Tenthpin Launches AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru
Switzerland based Tenthpin Management Consultants a global leader in management and technology consulting for Life Sciences companies has announced the launch of Innovation Hub in Bengaluru
Novo and Anthropic will collaborate to advance drug discovery with Claude
Novo Nordisk and Anthropic today announced a collaboration that will help Novo accelerate the development of new medicines and advance AIdriven software development
Leqembi® Pen subcutaneous formulation approved in Japan
BioArctic AB publs Nasdaq Stockholm BIOA B partner Eisai announced today that the subcutaneous autoinjector formulation of Leqembi known as Leqembi Pen in Japan has been approved as a new route of administration for the treatment of early Alzheimers disease
EventsRead more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality Summit
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWSRead more...
Dualitas Therapeutics and Roche Partner to Discover Bispecific Antibodies for I&I Diseases
Dualitas Therapeutics has announced a research collaboration and licence agreement with Roche to discover and develop novel bispecific antibody BsAb therapies for immunology and inflammation II diseases
Eisai and Biogen Receive Approval for LEQEMBI Pen for Early Alzheimer’s Disease
Eisai and Biogen have received approval in Japan for LEQEMBI Pen a subcutaneous SC formulation of lecanemab for the treatment of early Alzheimers disease AD
QurCan Therapeutics Enters into Collaboration with Lilly Advance Nucleic Acid Therapies for Nervous System Diseases
QurCan Therapeutics has entered into an exclusive research and collaboration agreement with Eli Lilly and Company to develop nucleic acid therapies for diseases affecting the central nervous system CNS and peripheral nervous system PNS
BostonGene Expands Collaboration with Dana-Farber Cancer Institute for Breast Cancer Research
BostonGene has expanded its scientific collaboration with DanaFarber Cancer Institute to study the biological mechanisms involved in breast cancers associated with BRCA and BRCA mutations
Telix Receives Approval for Pixclara for Brain Cancer Imaging
Telix Pharmaceuticals has received approval from the US Food and Drug Administration FDA for Pixclara floretyrosine F or FFET a radioactive diagnostic drug used with positron emission tomography PET to image gliomas a type of brain cancer
Evonik Expands Biotechnology Manufacturing Capacity in Slovakia
Evonik has started construction of a biotechnology expansion at its Fermas site in Slovensk upa Slovakia